Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryopreservation of Autologous Blood Nuclear Cells for Intensive Regimen of Extracorporeal Photopheresis in Steroid Resistant GVHD
NCT03361254Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Mar 2020
- Primary completion
- Jun 2020
01
Overview
Open-label, single-arm trial in graft-versus-host disease (GVHD), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Intensity of ECP regimen at 3 months. Status: unknown.
02
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03361254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03361254.